Dr. Brown, whose research has been shedding light on the development of the early life immune system and its relationship to autoimmunity, allergy, inflammation and cancer, was among 30 early career scientists nationwide selected for the 2025 class of scholars.
Thetis cells, a class of immune cells first described by MSK researchers in 2022, play an essential and previously unknown role in suppressing inflammatory responses to food, a new study finds.
Hear from three women breaking new ground in the fields of cancer metastasis, immunology and philanthropy.
Learn how Dr. Chrysothemis Brown is shedding light on new types of immune cells and their role in cancer and other diseases.
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:Jennifer Oakvik and Adrienne Bloom Recognized by the...
New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute suggests a therapeutic strategy to overcome resistance to PRMT5 inhibition in lymphoma; finds safety and clinical benefit using an engineered adenovirus in combination with immunotherapy against PD-1-resistant melanoma; and uncovers a new type of immune cell that plays a key role in establishing a healthy gut microbiome.
MSK announces the establishment of The Tow Center for Developmental Oncology (TCDO).
In the Lab
Dendritic cells, the guards of the immune system, have a previously unrecognized division of labor.
